Evidence-Based Role of Janus Kinases in the Management of Rheumatoid Arthritis

Evidence-Based Role of Janus Kinases in the Management of Rheumatoid Arthritis is organized by North American Center for Continuing Medical Education (NACCME) and would be held during Dec 16, 2016 - Dec 16, 2017.The Target audience basically for this Event Rheumatologists.This CME conference has been approved with a maximum of 1 AMA PRA Category 1 Credit.

Objectives
•Explain the mechanism of action, safety, and efficacy of current and emerging Janus Kinase (JAK)-inhibitors for the treatment of RA
•Describe the evidence supporting the use of JAK-inhibitors in the management of RA and their place within the treatment armamentarium.